Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

RNA silencing technique developed by spinoff from UM-Madison effective in battling hepatitis B

Researchers develop computational algorithm to analyze big genomic data for different cancers

Researchers develop computational algorithm to analyze big genomic data for different cancers

Increased treatment for HCV in Rhode Island could help eradicate disease by 2030

Increased treatment for HCV in Rhode Island could help eradicate disease by 2030

Research could help develop better therapies for new subtype of adenocarcinoma  patients

Research could help develop better therapies for new subtype of adenocarcinoma patients

Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

Research could help clinicians identify patients who may benefit from targeted therapy for liver cancer

Researchers identify new mechanisms capable of suppressing propagation of HCV

Researchers identify new mechanisms capable of suppressing propagation of HCV

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

New screen-and-treat programme for hepatitis B may thwart deadly complications of disease

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Low levels of blood selenium may increase risk of liver cancer

Low levels of blood selenium may increase risk of liver cancer

Infant HBV vaccination prevents HCC in children, young adults

Infant HBV vaccination prevents HCC in children, young adults

TDF reduces vertical HBV transmission

TDF reduces vertical HBV transmission

Targeted molecular therapy reduces initial development of NAFLD in mice

Targeted molecular therapy reduces initial development of NAFLD in mice

Researchers develop in vitro model system for investigating etiology of NAFLD

Researchers develop in vitro model system for investigating etiology of NAFLD

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Clinical trial finds pioglitazone drug safe and effective for NASH patients

Clinical trial finds pioglitazone drug safe and effective for NASH patients

Potential therapeutic approaches to combat chronic myeloid leukemia

Potential therapeutic approaches to combat chronic myeloid leukemia

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot beverages may increase risk of esophagus tumors

Portal vein hypertension diminishes after hepatitis C recovery

Portal vein hypertension diminishes after hepatitis C recovery

Disruption of SVIP protein can lead to cardiovascular, fatty liver disease

Disruption of SVIP protein can lead to cardiovascular, fatty liver disease

Pre-procedure medication regimen could lower incidence of hospital readmission in lung caner patients

Pre-procedure medication regimen could lower incidence of hospital readmission in lung caner patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.